Literature DB >> 1372213

Treatment of breast cancer in the 1990s. What does the future hold?

R B Jones1, E J Shpall.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1372213     DOI： 10.2165/00003495-199243020-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  19 in total

Review 1.  Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.

Authors:  G Bonadonna
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

2.  Adjuvant CMF chemotherapy in operable breast cancer: ten years later.

Authors:  G Bonadonna; A Rossi; P Valagussa
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

3.  Number of lymph nodes examined and the prognosis of breast carcinoma.

Authors:  B Fisher; N H Slack
Journal:  Surg Gynecol Obstet       Date:  1970-07

4.  Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis.

Authors:  D A Decker; D L Ahmann; H F Bisel; J H Edmonson; R G Hahn; J R O'Fallon
Journal:  JAMA       Date:  1979-11-09       Impact factor: 56.272

5.  Barrier function of lymph node to tumor cells and erythrocytes. I. Normal nodes.

Authors:  B Fisher; E R Fisher
Journal:  Cancer       Date:  1967-11       Impact factor: 6.860

Review 6.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

7.  High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer.

Authors:  S F Williams; R Mick; R Desser; J Golick; J Beschorner; J D Bitran
Journal:  J Clin Oncol       Date:  1989-12       Impact factor: 44.544

8.  High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

Authors:  T Philip; J O Armitage; G Spitzer; F Chauvin; S Jagannath; J Y Cahn; P Colombat; A H Goldstone; N C Gorin; M Flesh
Journal:  N Engl J Med       Date:  1987-06-11       Impact factor: 91.245

9.  Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer.

Authors:  T J Powles; R C Coombes; I E Smith; J M Jones; H T Ford; J C Gazet
Journal:  Lancet       Date:  1980-03-15       Impact factor: 79.321

10.  The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer.

Authors:  M H Bronchud; A Howell; D Crowther; P Hopwood; L Souza; T M Dexter
Journal:  Br J Cancer       Date:  1989-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.